• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外囊泡可增强头孢噻呋对细胞内细菌感染的疗效。

Extracellular vesicles enhance the efficacy of ceftiofur against intracellular bacterial infections.

作者信息

Yuan Pingping, Zhou Shijie, Li Qianqian, Li Lin, Qu Shaoqi

机构信息

College of Veterinary Medicine, Anhui Agricultural University, Hefei, 230036, China.

Center for the Creation and Evaluation of New Veterinary Drugs, Anhui Agricultural University, Hefei, 230036, China.

出版信息

Synth Syst Biotechnol. 2025 Jul 3;10(4):1200-1207. doi: 10.1016/j.synbio.2025.07.001. eCollection 2025 Dec.

DOI:10.1016/j.synbio.2025.07.001
PMID:40727487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12301761/
Abstract

Bacterial infections pose a major threat to human health and economic stability. In particular, intracellular bacterial infections present significant clinical challenges due to antibiotic resistance and poor drug penetration. Therefore, there is an urgent need to develop novel therapeutic strategies to address the problem of intracellular bacterial infections. Extracellular bacterial vesicles become ideal delivery systems due to their natural targeting properties. Here, we developed a bacteria-derived extracellular vesicles (EVs)-based drug delivery platform to enhance the therapeutic efficacy of antibiotics against intracellular infections. EVs were successfully isolated and increased production from  by ultracentrifugation, then loaded with ceftiofur (CEF) via co-incubation.  tests demonstrated the potent antibacterial activity of CEF, achieving complete growth inhibition within 24 h and a 4-log viability reduction in 4 h. Furthermore, confocal microscopy revealed efficient CEV internalization in IEC-6 cells, with 12-fold greater intracellular bacterial clearance than free CEF. , CEV-incorporated hydrogel (CEVH) significantly reduced both intra- and extracellular bacterial loads and accelerated wound healing. These findings demonstrate that bacterial EVs serve as a universal delivery platform to significantly enhance the efficacy of existing antibiotics against intracellular infections.

摘要

细菌感染对人类健康和经济稳定构成重大威胁。特别是,由于抗生素耐药性和药物渗透性差,细胞内细菌感染带来了重大的临床挑战。因此,迫切需要开发新的治疗策略来解决细胞内细菌感染问题。细胞外细菌囊泡因其天然的靶向特性而成为理想的递送系统。在此,我们开发了一种基于细菌衍生的细胞外囊泡(EVs)的药物递送平台,以提高抗生素对细胞内感染的治疗效果。通过超速离心成功分离并增加了EVs的产量,然后通过共孵育加载头孢噻呋(CEF)。测试证明了CEF具有强大的抗菌活性,在24小时内实现完全生长抑制,4小时内活菌数量减少4个对数级。此外,共聚焦显微镜显示CEV在IEC-6细胞中有效内化,细胞内细菌清除率比游离CEF高12倍。含CEV的水凝胶(CEVH)显著降低了细胞内和细胞外的细菌载量,并加速了伤口愈合。这些发现表明,细菌EVs作为一种通用的递送平台,可显著提高现有抗生素对细胞内感染的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/75593d20bba7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/e9463be1622e/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/3427e2b5ca7a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/2598084398a1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/a2a34926e7c4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/75593d20bba7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/e9463be1622e/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/3427e2b5ca7a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/2598084398a1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/a2a34926e7c4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d0/12301761/75593d20bba7/gr4.jpg

相似文献

1
Extracellular vesicles enhance the efficacy of ceftiofur against intracellular bacterial infections.细胞外囊泡可增强头孢噻呋对细胞内细菌感染的疗效。
Synth Syst Biotechnol. 2025 Jul 3;10(4):1200-1207. doi: 10.1016/j.synbio.2025.07.001. eCollection 2025 Dec.
2
Quantitative characterisation of extracellular vesicles designed to decoy or compete with SARS-CoV-2 reveals differential mode of action across variants of concern and highlights the diversity of Omicron.旨在与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱饵或竞争的细胞外囊泡的定量表征揭示了针对不同关注变体的不同作用模式,并突出了奥密克戎的多样性。
Cell Commun Signal. 2025 Jul 2;23(1):323. doi: 10.1186/s12964-025-02223-x.
3
Reassessment of extracellular and intracellular activity of macrolides, rifampicin, and doxycycline against based on bacterial counts and microscopy.基于细菌计数和显微镜检查对大环内酯类、利福平及多西环素的细胞外和细胞内活性进行重新评估。
Microbiol Spectr. 2025 Jul 29:e0120525. doi: 10.1128/spectrum.01205-25.
4
Identification of an antibiotic from an HTS targeting EF-Tu:tRNA interaction: a prospective topical treatment for MRSA skin infections.从针对延伸因子 Tu(EF-Tu)与转运 RNA(tRNA)相互作用的高通量筛选中鉴定出一种抗生素:一种针对耐甲氧西林金黄色葡萄球菌(MRSA)皮肤感染的前瞻性局部治疗方法。
Appl Environ Microbiol. 2025 Jan 31;91(1):e0204624. doi: 10.1128/aem.02046-24. Epub 2024 Dec 23.
5
Isolation and characterization of bone mesenchymal cell small extracellular vesicles using a novel mouse model.利用新型小鼠模型分离和鉴定骨髓间充质细胞的小细胞外囊泡。
J Bone Miner Res. 2024 Oct 29;39(11):1633-1643. doi: 10.1093/jbmr/zjae135.
6
The nucleobase analog 4-thiouracil hijacks the pyrimidine salvage pathway to inhibit growth.核碱基类似物4-硫尿嘧啶利用嘧啶补救途径来抑制生长。
Microbiol Spectr. 2025 Jul;13(7):e0064025. doi: 10.1128/spectrum.00640-25. Epub 2025 May 27.
7
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.生物标志物作为即时检测手段,指导初级保健中急性呼吸道感染患者使用抗生素的处方。
Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD010130. doi: 10.1002/14651858.CD010130.pub3.
8
Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients.用于预防外科手术患者耐甲氧西林金黄色葡萄球菌(MRSA)相关并发症的抗生素预防措施。
Cochrane Database Syst Rev. 2013 Aug 19;2013(8):CD010268. doi: 10.1002/14651858.CD010268.pub2.
9
A systematic review on natural products with antimicrobial potential against WHO's priority pathogens.关于对世界卫生组织重点病原体具有抗菌潜力的天然产物的系统评价。
Eur J Med Res. 2025 Jul 1;30(1):525. doi: 10.1186/s40001-025-02717-x.
10
Alcohol Sanitizer酒精消毒剂

本文引用的文献

1
Proteomic and metabolomic profiling of extracellular vesicles produced by human gut archaea.人类肠道古菌产生的细胞外囊泡的蛋白质组学和代谢组学分析
Nat Commun. 2025 Jun 3;16(1):5094. doi: 10.1038/s41467-025-60271-w.
2
toxicity of chitosan-based nanoparticles: a systematic review.基于壳聚糖的纳米颗粒的毒性:一项系统综述。
Artif Cells Nanomed Biotechnol. 2025 Dec;53(1):1-15. doi: 10.1080/21691401.2025.2462328. Epub 2025 Feb 9.
3
Size distribution of extracellular vesicles in pretreatment ascites and plasma is correlated with primary treatment outcome in advanced high-grade serous carcinoma.
晚期高级别浆液性癌患者预处理腹水和血浆中细胞外囊泡的大小分布与初始治疗结果相关。
Sci Rep. 2025 Feb 6;15(1):4500. doi: 10.1038/s41598-025-88707-9.
4
Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism.通过TRAIN机制利用巨噬细胞-药物偶联物进行实体瘤的异基因细胞疗法。
Nat Commun. 2025 Feb 4;16(1):1327. doi: 10.1038/s41467-025-56637-9.
5
Bone marrow mesenchymal stem cell-derived extracellular vesicles alleviate diabetes-exacerbated atherosclerosis via AMPK/mTOR pathway-mediated autophagy-related macrophage polarization.骨髓间充质干细胞衍生的细胞外囊泡通过AMPK/mTOR途径介导的自噬相关巨噬细胞极化减轻糖尿病加重的动脉粥样硬化。
Cardiovasc Diabetol. 2025 Jan 29;24(1):48. doi: 10.1186/s12933-025-02603-0.
6
Antibiotic susceptibility testing using minimum inhibitory concentration (MIC) assays.使用最低抑菌浓度(MIC)测定法进行抗生素敏感性测试。
NPJ Antimicrob Resist. 2024 Nov 7;2(1):37. doi: 10.1038/s44259-024-00051-6.
7
Review on bacterial outer membrane vesicles: structure, vesicle formation, separation and biotechnological applications.细菌外膜囊泡综述:结构、囊泡形成、分离及生物技术应用
Microb Cell Fact. 2025 Jan 21;24(1):27. doi: 10.1186/s12934-025-02653-9.
8
Different storage and freezing protocols for extracellular vesicles: a systematic review.不同的细胞外囊泡储存和冷冻方案:系统综述。
Stem Cell Res Ther. 2024 Nov 26;15(1):453. doi: 10.1186/s13287-024-04005-7.
9
Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications.靶向细胞外囊泡递送:机制、技术和治疗应用。
Mol Biomed. 2024 Nov 21;5(1):60. doi: 10.1186/s43556-024-00230-x.
10
Collagen-Based Nanoparticles as Drug Delivery System in Wound Healing Applications.基于胶原蛋白的纳米粒子作为药物传递系统在创伤愈合中的应用。
Int J Nanomedicine. 2024 Nov 6;19:11321-11341. doi: 10.2147/IJN.S485588. eCollection 2024.